HLA system 1 Review 1 adjuvant therapy 1 anthracycline 1 antiapoptotic activity 1 antibody drug conjugate 1 atezolizumab 1 biological marker 1 breast cancer 1 cancer chemotherapy 1 cancer immunotherapy 1 cancer prognosis 1 capecitabine 1 carboplatin 1 circulating tumor DNA 1 colitis 1 cyclophosphamide 1 disease exacerbation 1 disease free survival 1 distant disease free survival durvalumab 1 estrogen receptor 1 event free survival 1 financial distress 1 hepatitis 1 hormone receptor positive breast cancer 1 hyperthyroidism 1 hypophysitis 1 hypothyroidism 1 immune checkpoint inhibitor 1